Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Courtney Cubrich"'
Autor:
Phil Eastlake, Derek Murphy, Donna Neuberg, Rafael Bejar, Benjamin L. Ebert, G. Mike Makrigiorgos, Katherine Richardson, Yanggu Shi, Courtney Cubrich, Kristen E. Stevenson, Hagop M. Kantarjian, Guillermo Garcia-Manero
Publikováno v:
Leukemia. 27:2077-2081
NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ab712ebea7927403a9136b4aba9391b
https://doi.org/10.1038/leu.2013.160
https://doi.org/10.1038/leu.2013.160
Autor:
Stephanie Veys, Grant Wu, Jason Stoddard, Erin Montagne, Benjamin Legendre, Vicki Rosendale, Kylee Baughman, Paula Bartlett, Phil Eastlake, Amy Kruempel, Sheena Jensen, Phil Krzycki, Sarah Cherubin, Sarah Statt, Stephanie Peterson, Emily McCutchen, Karissa Scott, Courtney Cubrich, Jaclyn Pope, Katherine Richardson
Publikováno v:
Cancer Research. 75:5438-5438
Introduction: The use of “liquid biopsies”, where limited or no tumor tissue is available, is increasingly important for molecular demographics, diagnostics and pharmacodynamic monitoring of patients during therapy. The ICE COLD-PCR (ICP) techniq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50b86fac8682a3e04293c10c4e597eef
https://doi.org/10.1158/1538-7445.am2015-5438
https://doi.org/10.1158/1538-7445.am2015-5438
Publikováno v:
Cancer Research. 74:1506-1506
Next-Generation Sequencing (NGS) allows high throughput mutation analysis of oncogenes and tumor suppressor genes by targeted resequencing. However, increased sensitivity for mutation detection due to the spatial heterogeneity of the solid tumor or t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e6f4ea185460db7c4c7356073d5ef57
https://doi.org/10.1158/1538-7445.am2014-1506
https://doi.org/10.1158/1538-7445.am2014-1506
Autor:
Vivek Subbiah, Goran Cabrilo, Rajyalakshmi Luthra, Apostolia Maria Tsimberidou, Bryan K. Kee, Ralph Zinner, Gerald S. Falchook, Kevin B. Kim, Siqing Fu, Grant Wu, Agop Y. Bedikian, Katherine Richardson, Jennifer J. Wheler, Ben Legendre, Sarina Anne Piha-Paul, Courtney Cubrich, Jaclyn Pope, Razelle Kurzrock, Veronica R. Holley, Filip Janku, Cathy Eng, Aung Naing, Vanda M. Stepanek, Daniel D. Karp, Michael J. Overman, Marcia Lewis, David S. Hong, Amy Kruempel, Funda Meric-Bernstam
Publikováno v:
Cancer Research. 74:5607-5607
Background: Cell-free (cf) DNA in the plasma of cancer patients offers an easily obtainable, low-risk, inexpensive, and repeatedly available source of biologic material for mutation analysis and monitoring of molecular changes throughout cancer thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8985677ef0c0f6ec8fd25a5222e76b3
https://doi.org/10.1158/1538-7445.am2014-5607
https://doi.org/10.1158/1538-7445.am2014-5607
Autor:
Filip Janku, Siqing Fu, Grant Wu, Katherine Richardson, Vivek Subbiah, Sarina Anne Piha-Paul, David S. Hong, Jennifer J. Wheler, Amy Kruempel, Razelle Kurzrock, Vanda M. Stepanek, Rajyalakshmi Luthra, Veronica R. Holley, Yanggu Shi, Apostolia Maria Tsimberidou, Marcia Lewis, Goran Cabrilo, Gerald S. Falchook, Courtney Cubrich, Jaclyn Pope, Ralph Zinner, Funda Meric-Bernstam, Ben Legendre, Aung Naing, Daniel D. Karp
Publikováno v:
Molecular Cancer Therapeutics. 12:C203-C203
Background: Cell-free (cf) DNA and circulating tumor cells (CTC) in the blood of cancer patients offer an easily obtainable, low-risk, inexpensive, and repeatedly available source of biologic material for mutation analysis and monitoring of molecular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12be47b8dbd50a8e9c34ef8db2250fcc
https://doi.org/10.1158/1535-7163.targ-13-c203
https://doi.org/10.1158/1535-7163.targ-13-c203
Autor:
Katherine A. Richardson, Yanggu Shi, Benjamin Legendre, Rui Lin, Courtney Cubrich, Grant Wu, Phil Eastlake, Stephanie Veys
Publikováno v:
Cancer Research. 72:2091-2091
The Androgen Receptor plays an important role in prostate cancer, androgen-dependent (AD) and androgen-independent (AI) disease progression. Anti-androgen therapies are the hallmark of prostate cancer treatment; however spontaneous AR mutations are o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebe18d4ba0ad916cb0a1bb98ea2574e9
https://doi.org/10.1158/1538-7445.am2012-2091
https://doi.org/10.1158/1538-7445.am2012-2091